These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11570511)

  • 1. Quantitation of retroviral-mediated transfer using luciferase in living and lysed cells.
    Zakhartchenko VA; Anderson WF; Rozenberg Y
    Biotechniques; 2001 Sep; 31(3):676, 678-81. PubMed ID: 11570511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of infection rate and selection pressure on gene expression from an internal promoter of a double gene retroviral vector.
    Schott B; Iraj ES; Roninson IB
    Somat Cell Mol Genet; 1996 Jul; 22(4):291-309. PubMed ID: 9000173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q vectors, bicistronic retroviral vectors for gene transfer.
    Julius MA; Yan Q; Zheng Z; Kitajewski J
    Biotechniques; 2000 Apr; 28(4):702-8. PubMed ID: 10769748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo.
    Lindemann D; Patriquin E; Feng S; Mulligan RC
    Mol Med; 1997 Jul; 3(7):466-76. PubMed ID: 9260158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved gene expression by a U3-based retroviral vector.
    Chen BF; Hsieh CL; Chen DS; Hwang LH
    Biochem Biophys Res Commun; 1992 Apr; 184(1):330-7. PubMed ID: 1567440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gene expression from the human c-erbB gene promoter by a retroviral vector expressing anti-gene RNA.
    Okada T; Amanuma H; Okada Y; Obata M; Hayashi Y; Yamaguchi K; Yamashita J
    Biochem Biophys Res Commun; 1997 Nov; 240(1):203-7. PubMed ID: 9367910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking and quantitation of retroviral-mediated transfer using a completely humanized, red-shifted green fluorescent protein gene.
    Muldoon RR; Levy JP; Kain SR; Kitts PA; Link CJ
    Biotechniques; 1997 Jan; 22(1):162-7. PubMed ID: 8994663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
    Addison CL; Hitt M; Kunsken D; Graham FL
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome-mediated gene transfer into human vascular smooth muscle cells.
    Pickering JG; Jekanowski J; Weir L; Takeshita S; Losordo DW; Isner JM
    Circulation; 1994 Jan; 89(1):13-21. PubMed ID: 8281638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
    Guan J; Ma L; Wei L
    Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.
    Scharfmann R; Axelrod JH; Verma IM
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4626-30. PubMed ID: 1905011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
    Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
    Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
    Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
    Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system.
    Wahlfors JJ; Morgan RA
    Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.
    Fassati A; Bardoni A; Sironi M; Wells DJ; Bresolin N; Scarlato G; Hatanaka M; Yamaoka S; Dickson G
    Hum Gene Ther; 1998 Nov; 9(17):2459-68. PubMed ID: 9853513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of retroviral vector for clinical studies using transient transfection.
    Yang S; Delgado R; King SR; Woffendin C; Barker CS; Yang ZY; Xu L; Nolan GP; Nabel GJ
    Hum Gene Ther; 1999 Jan; 10(1):123-32. PubMed ID: 10022537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.